As of 2025-10-25, the Fair Value of Sangamo Therapeutics Inc (SGMO) is -2.43 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.63 USD, the upside of Sangamo Therapeutics Inc is -483.39%.
With the market price of 0.63 USD and our fair value calculation, Sangamo Therapeutics Inc (SGMO) is not a good investment. Investing in SGMO stocks now will result in a potential loss of 483.39%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -121.00 | -178.30 | -192.30 | -257.83 | -97.94 | -169.47 |
| YoY growth | -27.10% | -47.36% | -7.85% | -34.08% | 62.01% | -10.87% |
| Market Cap (mil) | 191.07 |
| P/E | |
| Forward P/E |
| EPS | -0.49 |
| Avg earnings growth rate | -10.87% |
| TTM earnings |